Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ANTHONY P MACARTHY

Allopathic & Osteopathic Physicians Family Medicine

NPI
1629300470
CMS profile
608617
Location
SILVER SPRING, MD

General Payments · PY2018–2024

$3,297.99

  • Reported across 189 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$607.42

33 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $607.42 33

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Otsuka America Pharmaceutical, Inc. $185.43 12
Lilly USA, LLC $119.24 5
PFIZER INC. $49.77 2
ABBVIE INC. $44.34 2
ITI, Inc. $38.19 2
Phadia US Inc. $35.89 2
NOVARTIS PHARMACEUTICALS CORPORATION $30.31 2
Novo Nordisk AS $22.99 1
Alkermes, Inc. $18.01 1
GlaxoSmithKline, LLC. $18.01 1
Exact Sciences Corporation $17.34 1
Amgen Inc. $14.56 1
Astellas Pharma US Inc $13.34 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $23.59 2
PY2019 $71.74 4
PY2020 $443.44 25
PY2021 $498.52 32
PY2022 $837.84 47
PY2023 $815.44 46
PY2024 $607.42 33

Payment records · PY2024 (33)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $18.57 07/11/2024 Food and Beverage Undisputed 01/23/2026 1104918314 CMS
ABBVIE INC. $25.77 10/16/2024 Food and Beverage Undisputed 01/23/2026 1104918316 CMS
Alkermes, Inc. $18.01 02/02/2024 Food and Beverage Undisputed 01/23/2026 1120545379 CMS
Amgen Inc. $14.56 12/12/2024 Food and Beverage Undisputed 01/23/2026 1117315818 CMS
Astellas Pharma US Inc $13.34 10/03/2024 Food and Beverage Undisputed 01/23/2026 1139401841 CMS
Exact Sciences Corporation $17.34 09/18/2024 Food and Beverage Undisputed 01/23/2026 1114766566 CMS
GlaxoSmithKline, LLC. $18.01 04/01/2024 Food and Beverage Undisputed 01/23/2026 1116560698 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.10 03/14/2024 Food and Beverage Undisputed 01/23/2026 1143268180 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.09 07/10/2024 Food and Beverage Undisputed 01/23/2026 1143268184 CMS
Lilly USA, LLC $22.92 02/08/2024 Food and Beverage Undisputed 01/23/2026 1136044116 CMS
Lilly USA, LLC $19.84 05/02/2024 Food and Beverage Undisputed 01/23/2026 1136048687 CMS
Lilly USA, LLC $23.50 08/12/2024 Food and Beverage Undisputed 01/23/2026 1136044118 CMS
Lilly USA, LLC $27.13 09/30/2024 Food and Beverage Undisputed 01/23/2026 1136048721 CMS
Lilly USA, LLC $25.85 10/31/2024 Food and Beverage Undisputed 01/23/2026 1136048723 CMS
Novartis Pharmaceuticals Corporation $14.59 02/08/2024 Food and Beverage Undisputed 01/23/2026 1087106944 CMS
Novartis Pharmaceuticals Corporation $15.72 05/17/2024 Food and Beverage Undisputed 01/23/2026 1087106960 CMS
Novo Nordisk Inc $22.99 11/13/2024 Food and Beverage Undisputed 01/23/2026 1097185820 CMS
Otsuka America Pharmaceutical, Inc. $6.17 01/02/2024 Food and Beverage Undisputed 01/23/2026 1118933128 CMS
Otsuka America Pharmaceutical, Inc. $20.33 01/04/2024 Food and Beverage Undisputed 01/23/2026 1118933130 CMS
Otsuka America Pharmaceutical, Inc. $13.41 02/15/2024 Food and Beverage Undisputed 01/23/2026 1118933132 CMS
Otsuka America Pharmaceutical, Inc. $13.20 03/13/2024 Food and Beverage Undisputed 01/23/2026 1118933134 CMS
Otsuka America Pharmaceutical, Inc. $14.29 04/17/2024 Food and Beverage Undisputed 01/23/2026 1118933136 CMS
Otsuka America Pharmaceutical, Inc. $16.11 05/14/2024 Food and Beverage Undisputed 01/23/2026 1118933138 CMS
Otsuka America Pharmaceutical, Inc. $12.73 06/27/2024 Food and Beverage Undisputed 01/23/2026 1118933140 CMS
Otsuka America Pharmaceutical, Inc. $14.80 08/08/2024 Food and Beverage Undisputed 01/23/2026 1118933142 CMS
Otsuka America Pharmaceutical, Inc. $19.63 08/20/2024 Food and Beverage Undisputed 01/23/2026 1118933144 CMS
Otsuka America Pharmaceutical, Inc. $21.67 09/11/2024 Food and Beverage Undisputed 01/23/2026 1118933146 CMS
Otsuka America Pharmaceutical, Inc. $19.70 10/29/2024 Food and Beverage Undisputed 01/23/2026 1118933148 CMS
Otsuka America Pharmaceutical, Inc. $13.39 12/04/2024 Food and Beverage Undisputed 01/23/2026 1118933150 CMS
PFIZER INC. $29.41 06/13/2024 Food and Beverage Undisputed 01/23/2026 1131672154 CMS
PFIZER INC. $20.36 10/09/2024 Food and Beverage Undisputed 01/23/2026 1130881532 CMS
Phadia US Inc. $17.09 04/04/2024 Food and Beverage Undisputed 01/23/2026 1067575792 CMS
Phadia US Inc. $18.80 07/31/2024 Food and Beverage Undisputed 01/23/2026 1067575794 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.